What is 5-EAPB?
5-EAPB or (1-(benzofuran-5-yl)-N-ethylpropan-2-amine is the latest replacement for the recently banned APB series of compound. Amongst those prohibited within the UK temporary class drug order were 5-MAPB, 5-APB, 6-APB and 6-MAPB. Chemically, 5-EAPB is the N-ethyl derivative of the popular 5-APB which was reported to act as a stimulant amphetamine like entactogen. 5-APB supposedly acted upon the 5HT2C receptor as an agonist as well as having a triple monoamine re-uptake inhibitor action. To date, very little research has been conducted on this novel fine chemical, so it offers a fantastic opportunity for the study of n-ethyl APB derivatives.
What is 5-EAPB used for?
As a derivative of 5-APB, it is most appropriate to assume a similar action upon receptors, as such, research should be conducted in vitro (outside living organism) upon the relevant predicted receptor groups; seretonin, dopamine and norepinephrine. Full ligand binding assays should be conducted, as well as melting and boiling point analysis.
5-EAPB may be used as a reference sample for GC/MS, FTIR, HPLC or NMR analysis for addition into a chemistry library of novel fine chemicals, or to be used by toxicologists and forensic scientists. 5-EAPB may also be used as a reagent for chemical testing.
Please note: our 5-EAPB pellets are made for those wishing to purchase a pre-weighed pellet form, to avoid accidental spillage and inhalation. Each pellets contains 125mg 5-EAPB for in vitro use only. Each pellet also contains standard binding and flowing agents such as Microcrytalline Cellulose, Magnesium Stearate and Dicalcium Phosphate.
Buy 5-EAPB from Purechemshop.com
Only pure 5-EAPB is offered in both pure powder and pellet form. We only buy our fine chemicals from accredited laboratories where we can be sure of the synthesis route and purity of final product. Whole sale enquiries are always welcome
All orders of 5-EAPB are strictly not for human consumption and must only be used for legitimate research chemical purposes by customers over the age of 18.